诺华-话题@MedSci

#诺华#

235篇内容 | 5406人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1282713, encodeId=4d731282e1317, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=美国授予诺华公司“Kisqali”“突破”地位, objectType=article, longId=125470, objectId=d8ca1254e01a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8ca1254e01a, replyNumber=0, likeNumber=58, createdTime=2018-01-05, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8ca1254e01a, moduleTitle=美国授予诺华公司“Kisqali”“突破”地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8ca1254e01a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282712, encodeId=01cd1282e123f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的Kymriah在血癌中表现出持久应答, objectType=article, longId=123089, objectId=002e12308911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=002e12308911, replyNumber=0, likeNumber=56, createdTime=2017-12-13, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=002e12308911, moduleTitle=诺华的Kymriah在血癌中表现出持久应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=002e12308911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282711, encodeId=a8f91282e116e, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期, objectType=article, longId=122722, objectId=f09b122e2259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09b122e2259, replyNumber=0, likeNumber=63, createdTime=2017-12-09, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09b122e2259, moduleTitle=诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f09b122e2259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282710, encodeId=b3e31282e10f9, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华连续三年蝉联“中国杰出雇主”认证, objectType=article, longId=122483, objectId=ee1e122483eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee1e122483eb, replyNumber=0, likeNumber=80, createdTime=2017-12-08, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee1e122483eb, moduleTitle=诺华连续三年蝉联“中国杰出雇主”认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee1e122483eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282709, encodeId=83f81282e0933, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=真实世界数据：诺华Entresto®可改善心衰患者生存质量, objectType=article, longId=121203, objectId=27d6121203dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d6121203dd, replyNumber=0, likeNumber=92, createdTime=2017-11-25, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d6121203dd, moduleTitle=真实世界数据：诺华Entresto®可改善心衰患者生存质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d6121203dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282708, encodeId=f6a71282e086b, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华昌平工厂成立三十周年发展与创新座谈会在京举办, objectType=article, longId=120765, objectId=c415120e6581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c415120e6581, replyNumber=0, likeNumber=74, createdTime=2017-11-22, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c415120e6581, moduleTitle=诺华昌平工厂成立三十周年发展与创新座谈会在京举办, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c415120e6581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282707, encodeId=87241282e07f1, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%, objectType=article, longId=120485, objectId=e3de120485e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3de120485e7, replyNumber=0, likeNumber=75, createdTime=2017-11-19, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3de120485e7, moduleTitle=诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3de120485e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282706, encodeId=c9e21282e061b, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, objectType=article, longId=113448, objectId=2ab3113448b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab3113448b8, replyNumber=0, likeNumber=88, createdTime=2017-09-22, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab3113448b8, moduleTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab3113448b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282704, encodeId=28fd1282e0468, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华制药：抗VEGF药物疗效比较，头对头数据来验证, objectType=article, longId=112814, objectId=053511281469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=053511281469, replyNumber=0, likeNumber=73, createdTime=2017-09-16, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=053511281469, moduleTitle=诺华制药：抗VEGF药物疗效比较，头对头数据来验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=053511281469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282705, encodeId=f8711282e05dc, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华Cosentyx(R)5年III期数据展现出持久疗效与安全性, objectType=article, longId=112819, objectId=a992112819c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a992112819c5, replyNumber=0, likeNumber=75, createdTime=2017-09-16, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a992112819c5, moduleTitle=诺华Cosentyx(R)5年III期数据展现出持久疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a992112819c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282703, encodeId=40ce1282e03c7, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, objectType=article, longId=111488, objectId=f6591114889d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6591114889d, replyNumber=0, likeNumber=91, createdTime=2017-09-01, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6591114889d, moduleTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6591114889d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282702, encodeId=ca6d1282e02c3, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, objectType=article, longId=111487, objectId=17ca11148e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ca11148e2c, replyNumber=0, likeNumber=78, createdTime=2017-09-01, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ca11148e2c, moduleTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ca11148e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282700, encodeId=c1221282e0000, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华III期临床研究显示ACZ885可降低心脏病发作幸存者心血管风险, objectType=article, longId=107035, objectId=461b10e035bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=461b10e035bf, replyNumber=0, likeNumber=97, createdTime=2017-07-30, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=461b10e035bf, moduleTitle=诺华III期临床研究显示ACZ885可降低心脏病发作幸存者心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=461b10e035bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282701, encodeId=386d1282e0154, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华研究显示RTH258(brolucizumab)可助nAMD患者视力得到稳健改善, objectType=article, longId=107036, objectId=3e5410e036f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5410e036f2, replyNumber=0, likeNumber=76, createdTime=2017-07-30, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5410e036f2, moduleTitle=诺华研究显示RTH258(brolucizumab)可助nAMD患者视力得到稳健改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5410e036f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282699, encodeId=f8a3128269938, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐, objectType=article, longId=105399, objectId=1de4105399b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1de4105399b0, replyNumber=0, likeNumber=65, createdTime=2017-07-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1de4105399b0, moduleTitle=CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1de4105399b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282698, encodeId=5d481282698cc, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效, objectType=article, longId=101046, objectId=c56d10104674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c56d10104674, replyNumber=0, likeNumber=62, createdTime=2017-06-05, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c56d10104674, moduleTitle=数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c56d10104674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282697, encodeId=79b3128269e36, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华Zykadia获批一线治疗ALK阳性非小细胞肺癌, objectType=article, longId=100354, objectId=1e69100354f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e69100354f5, replyNumber=0, likeNumber=84, createdTime=2017-06-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e69100354f5, moduleTitle=诺华Zykadia获批一线治疗ALK阳性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e69100354f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282696, encodeId=f88312826960e, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华CAR-T CTL019再获突破性疗法认定, objectType=article, longId=96403, objectId=ca1f96403c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1f96403c9, replyNumber=0, likeNumber=54, createdTime=2017-04-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1f96403c9, moduleTitle=诺华CAR-T CTL019再获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1f96403c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282695, encodeId=59a11282695d0, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=意外之获！诺华心衰药物Entresto在3期临床试验中可改善血糖控制, objectType=article, longId=96279, objectId=06a2962e9cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06a2962e9cc, replyNumber=0, likeNumber=56, createdTime=2017-04-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06a2962e9cc, moduleTitle=意外之获！诺华心衰药物Entresto在3期临床试验中可改善血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06a2962e9cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282694, encodeId=28191282694a5, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华CAR- T疗法今日获美国FDA优先审评资格, objectType=article, longId=94099, objectId=468f940997e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468f940997e, replyNumber=0, likeNumber=68, createdTime=2017-04-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468f940997e, moduleTitle=诺华CAR- T疗法今日获美国FDA优先审评资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468f940997e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诺华

2020-05-29发表于威斯康星

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

美国授予诺华公司“Kisqali”“突破”地位

2018-01-05

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的Kymriah在血癌中表现出持久应答

2017-12-13

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期

2017-12-09

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华连续三年蝉联“中国杰出雇主”认证

2017-12-08

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

真实世界数据：诺华Entresto®可改善心衰患者生存质量

2017-11-25

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华昌平工厂成立三十周年发展与创新座谈会在京举办

2017-11-22

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华ACZ885在III期临床试验CANTOS受试者亚组中降低心血管风险25%

2017-11-19

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生

2017-09-22

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华制药：抗VEGF药物疗效比较，头对头数据来验证

2017-09-16

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华Cosentyx(R)5年III期数据展现出持久疗效与安全性

2017-09-16

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

美国食药监局正式批准诺华公司CAR-T疗法，系全球首例

2017-09-01

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

美国食药监局正式批准诺华公司CAR-T疗法，系全球首例

2017-09-01

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华III期临床研究显示ACZ885可降低心脏病发作幸存者心血管风险

2017-07-30

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华研究显示RTH258(brolucizumab)可助nAMD患者视力得到稳健改善

2017-07-30

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐

2017-07-14

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

数据公布，诺华新一代CAR-T疗法CTL119取得优异疗效

2017-06-05

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华Zykadia获批一线治疗ALK阳性非小细胞肺癌

2017-06-02

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华CAR-T CTL019再获突破性疗法认定

2017-04-21

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

意外之获！诺华心衰药物Entresto在3期临床试验中可改善血糖控制

2017-04-02

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华CAR- T疗法今日获美国FDA优先审评资格

2017-04-01

科室
- - 订阅+
  - 更多科室
工具
服务